Kronox Lab Sciences Ltd (KRONOX) - Total Liabilities
Based on the latest financial reports, Kronox Lab Sciences Ltd (KRONOX) has total liabilities worth Rs113.96 Million INR (≈ $1.23 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Kronox Lab Sciences Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Kronox Lab Sciences Ltd - Total Liabilities Trend (2022–2026)
This chart illustrates how Kronox Lab Sciences Ltd's total liabilities have evolved over time, based on quarterly financial data. See KRONOX FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Kronox Lab Sciences Ltd Competitors by Total Liabilities
The table below lists competitors of Kronox Lab Sciences Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kredyt Inkaso SA
WAR:KRI
|
Poland | zł564.43 Million |
|
Senzime AB
ST:SEZI
|
Sweden | Skr66.51 Million |
|
Korea Computer & Systems Inc
KQ:115500
|
Korea | ₩7.26 Billion |
|
Nurminen Logistics Oyj
HE:NLG1V
|
Finland | €57.24 Million |
|
Tong Herr Resources Bhd
KLSE:5010
|
Malaysia | RM121.89 Million |
|
China Tianrui Group Cement Company Limited
F:T18
|
Germany | €20.27 Billion |
|
Glomac Bhd
KLSE:5020
|
Malaysia | RM595.74 Million |
Liability Composition Analysis (2022–2026)
This chart breaks down Kronox Lab Sciences Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Kronox Lab Sciences Ltd market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 7.60 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.10 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.09 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Kronox Lab Sciences Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Kronox Lab Sciences Ltd (2022–2026)
The table below shows the annual total liabilities of Kronox Lab Sciences Ltd from 2022 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | Rs113.96 Million ≈ $1.23 Million |
+30.67% |
| 2025-03-31 | Rs87.22 Million ≈ $943.20K |
+13.43% |
| 2024-03-31 | Rs76.89 Million ≈ $831.56K |
-17.81% |
| 2023-03-31 | Rs93.55 Million ≈ $1.01 Million |
-43.08% |
| 2022-03-31 | Rs164.35 Million ≈ $1.78 Million |
-- |
About Kronox Lab Sciences Ltd
Kronox Lab Sciences Limited manufactures and sells fine chemicals, inorganic chemicals, phosphates, and metallic chemicals in India and internationally. The company provides bulk reagents comprising ACS reagents, as well as LR, AR, and GR reagents; bulk ingredients that includes oral care, pharmacopoeia, food and nutraceutical, personal care and cosmetics, and veterinary pharma and animal health;… Read more